Screening and identification of potential target of 1′-acetoxychavicol acetate (ACA) in acquired lapatinib-resistant breast cancer
1′-Acetoxychavicol acetate (ACA) eliminates breast cancer cells via the HER2/MAPK/ERK1/2 and PI3K/AKT pathways, and it also directly influences endocrine resistance by both enhancing pro-apoptotic signals and suppressing pro-survival molecules. This study utilized bioinformatics to assess ACA target...
Saved in:
| Main Authors: | Febri Wulandari, Ahmad Fauzi, Muhammad Da'i, Mahmoud Mirzaei, Maryati, Kun Harismah |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024168004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Natural Inhibitor, 1′<i>S</i>-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation
by: Kkotnara Park, et al.
Published: (2025-05-01) -
Association between efficacy and skin rash following treatment with the lapatinib in metastatic breast cancer
by: Suleyman Temiz, et al.
Published: (2016-04-01) -
Preparation and characterization of lapatinib-loaded PVP nanofiber amorphous solid dispersion by electrospinning
by: E. Bitay, et al.
Published: (2021-11-01) -
Lapatinib plus transtuzumab for HER-2 positiva metastatic breast cancer: Experience of use
by: C. García-Muñoz, et al.
Published: (2014-03-01) -
The effect of copper oxide nanoparticle conjugated with lapatinib on breast cancer cell line and evaluating the effect of this nanoparticle on caspase 8 gene expression
by: Masoumeh Valizadeh Talarposhti, et al.
Published: (2025-03-01)